274 related articles for article (PubMed ID: 32639582)
1. Associations between clinical features and therapy with macrophage subpopulations and T cells in inflammatory lesions in the aorta from patients with Takayasu arteritis.
Dos Santos JP; Artigiani Neto R; Mangueira CLP; Filippi RZ; Gutierrez PS; Westra J; Brouwer E; de Souza AWS
Clin Exp Immunol; 2020 Dec; 202(3):384-393. PubMed ID: 32639582
[TBL] [Abstract][Full Text] [Related]
2. Specific Follicular Helper T Cell Signature in Takayasu Arteritis.
Desbois AC; Régnier P; Quiniou V; Lejoncour A; Maciejewski-Duval A; Comarmond C; Vallet H; Rosenzwag M; Darrasse-Jèze G; Derian N; Pouchot J; Samson M; Bienvenu B; Fouret P; Koskas F; Garrido M; Sène D; Bruneval P; Cacoub P; Klatzmann D; Saadoun D
Arthritis Rheumatol; 2021 Jul; 73(7):1233-1243. PubMed ID: 33538119
[TBL] [Abstract][Full Text] [Related]
3. Th1 and Th17 cytokines drive inflammation in Takayasu arteritis.
Saadoun D; Garrido M; Comarmond C; Desbois AC; Domont F; Savey L; Terrier B; Geri G; Rosenzwajg M; Klatzmann D; Fourret P; Cluzel P; Chiche L; Gaudric J; Koskas F; Cacoub P
Arthritis Rheumatol; 2015 May; 67(5):1353-60. PubMed ID: 25604824
[TBL] [Abstract][Full Text] [Related]
4. Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis.
Matsumoto K; Suzuki K; Yoshimoto K; Seki N; Tsujimoto H; Chiba K; Takeuchi T
Arthritis Res Ther; 2019 Dec; 21(1):304. PubMed ID: 31888748
[TBL] [Abstract][Full Text] [Related]
5. Effector CD4+ T cell subsets in Takayasu arteritis - Differences between the peripheral blood and the aorta.
Savioli B; Torquato HFV; Paredes-Gamero EJ; Franco AFDV; Gigek CO; Artigiani Neto R; de Souza AWS
Clin Exp Immunol; 2024 May; ():. PubMed ID: 38766690
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenesis of large vessel vasculitides].
Arnold S; Holl Ulrich K; Lamprecht P
Z Rheumatol; 2020 Aug; 79(6):505-515. PubMed ID: 32430566
[TBL] [Abstract][Full Text] [Related]
7. The Immunopathology of Giant Cell Arteritis Across Disease Spectra.
Robinette ML; Rao DA; Monach PA
Front Immunol; 2021; 12():623716. PubMed ID: 33717128
[TBL] [Abstract][Full Text] [Related]
8. Takayasu arteritis: insights into immunopathology.
Seko Y
Jpn Heart J; 2000 Jan; 41(1):15-26. PubMed ID: 10807525
[TBL] [Abstract][Full Text] [Related]
9. A novel molecular mechanism of vascular fibrosis in Takayasu arteritis: macrophage-derived GPNMB promoting adventitial fibroblast extracellular matrix production in the aorta.
Dai X; Sun Y; Ma L; Hou J; Wang L; Gong Y; Sun X; Wu S; Wang J; Ji Z; Chen H; Ma L; Jiang L; Kong X
Transl Res; 2023 May; 255():128-139. PubMed ID: 36566014
[TBL] [Abstract][Full Text] [Related]
10. Difference in immunohistochemical characteristics between Takayasu arteritis and giant cell arteritis: It may be better to distinguish them in the same age.
Kurata A; Saito A; Hashimoto H; Fujita K; Ohno SI; Kamma H; Nagao T; Kobayashi S; Yamashina A; Kuroda M
Mod Rheumatol; 2019 Nov; 29(6):992-1001. PubMed ID: 30663925
[No Abstract] [Full Text] [Related]
11. Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis-Similarities and Differences.
Watanabe R; Berry GJ; Liang DH; Goronzy JJ; Weyand CM
Curr Rheumatol Rep; 2020 Aug; 22(10):68. PubMed ID: 32845392
[TBL] [Abstract][Full Text] [Related]
12. Targeting Mechanistic Target of Rapamycin Complex 1 Restricts Proinflammatory T Cell Differentiation and Ameliorates Takayasu Arteritis.
Zhang J; Zhao L; Wang J; Cheng Z; Sun M; Zhao J; Liu B; Liu X; Wen Z; Li Z
Arthritis Rheumatol; 2020 Feb; 72(2):303-315. PubMed ID: 31430047
[TBL] [Abstract][Full Text] [Related]
13. Arterial wall fibrosis in Takayasu arteritis and its potential for therapeutic modulation.
Misra DP; Singh K; Sharma A; Agarwal V
Front Immunol; 2023; 14():1174249. PubMed ID: 37256147
[TBL] [Abstract][Full Text] [Related]
14. Pro-fibrotic effect of IL-6 via aortic adventitial fibroblasts indicates IL-6 as a treatment target in Takayasu arteritis.
Kong X; Ma L; Ji Z; Dong Z; Zhang Z; Hou J; Zhang S; Ma L; Jiang L
Clin Exp Rheumatol; 2018; 36(1):62-72. PubMed ID: 28770707
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity?
Furuta S; Cousins C; Chaudhry A; Jayne D
J Rheumatol; 2015 Feb; 42(2):300-8. PubMed ID: 25399386
[TBL] [Abstract][Full Text] [Related]
16. Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis.
Grayson PC; Maksimowicz-McKinnon K; Clark TM; Tomasson G; Cuthbertson D; Carette S; Khalidi NA; Langford CA; Monach PA; Seo P; Warrington KJ; Ytterberg SR; Hoffman GS; Merkel PA;
Ann Rheum Dis; 2012 Aug; 71(8):1329-34. PubMed ID: 22328740
[TBL] [Abstract][Full Text] [Related]
17. Extra-cranial giant cell arteritis and Takayasu arteritis: How similar are they?
Kermani TA; Crowson CS; Muratore F; Schmidt J; Matteson EL; Warrington KJ
Semin Arthritis Rheum; 2015 Jun; 44(6):724-8. PubMed ID: 25712813
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cells and their function in Takayasu's arteritis.
Li T; Gao N; Cui W; Zhao L; Pan L
Clin Exp Rheumatol; 2020; 38 Suppl 124(2):84-90. PubMed ID: 32167875
[TBL] [Abstract][Full Text] [Related]
19. Takayasu arteritis and giant cell arteritis: a spectrum within the same disease?
Maksimowicz-McKinnon K; Clark TM; Hoffman GS
Medicine (Baltimore); 2009 Jul; 88(4):221-226. PubMed ID: 19593227
[TBL] [Abstract][Full Text] [Related]
20. The critical role of IL-6 in the pathogenesis of Takayasu arteritis.
Kong X; Sun Y; Ma L; Chen H; Wei L; Wu W; Ji Z; Ma L; Zhang Z; Zhang Z; Zhao Z; Hou J; Dai S; Yang C; Jiang L
Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S21-7. PubMed ID: 26633132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
